HIV & Herpes

What Are HIV & Herpes? 

HIV affects approximately 38 million people globally, while over 3.7 billion people under 50 are estimated to have HSV-1 and 491 million have HSV-2 (genital herpes). Effective antiretroviral therapy (ART) has transformed HIV from a terminal illness into a manageable chronic condition. AmozonPill stocks 58 generic HIV and herpes medications — including complete ART regimens, NRTI backbones, and herpes antivirals — sourced from WHO-prequalified, FDA-inspected manufacturers at up to 95% below innovator prices. 

 Drug Classes Available 

• Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs): Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF), Emtricitabine (FTC), Lamivudine (3TC), Abacavir — backbone of all WHO first-line and second-line ART regimens. TDF/FTC is the most widely used NRTI combination globally. 
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Efavirenz, Nevirapine, Rilpivirine, Etravirine — block HIV reverse transcriptase by binding adjacent to the active site. Efavirenz-based regimens remain first-line in many low-income countries due to low cost and proven efficacy. 
• Fixed-Dose Combination (FDC) Regimens: TDF + 3TC + Efavirenz (WHO first-line triple therapy), TDF + FTC + Efavirenz — single daily pill combinations providing complete first-line ART. Dramatically improve adherence vs separate tablets. 
• Herpes Simplex Antivirals: Acyclovir 200–800 mg, Valacyclovir 500–1000 mg, Famciclovir — treat HSV-1 and HSV-2 outbreaks and prevent recurrences. Valacyclovir is preferred for its simplified twice-daily dosing and better bioavailability. 
• Herpes Zoster (Shingles) Treatment: Valacyclovir 1000 mg three times daily for 7 days, Famciclovir 500 mg three times daily — must be started within 72 hours of rash onset for maximum efficacy. Reduces duration of pain and risk of post-herpetic neuralgia. 

Why Buy Generic? 

• Generic TDF+3TC+EFV from $12/month vs $400–$600+ for Atripla brand 
• Generic Valacyclovir from $18 vs $70+ for Valtrex brand 
• WHO-prequalified generic ARVs — same quality used in global HIV programmes 
• FDA-inspected, pharmacist-reviewed 
• Free shipping on orders over $199 

How to Choose the Right Product 

For HIV: antiretroviral therapy must be selected and initiated by an HIV physician or infectious disease specialist. The current WHO preferred first-line regimen is TDF + 3TC (or FTC) + Dolutegravir for adults. AmozonPill provides access to WHO-recommended generic ARV regimens. For genital herpes (first episode): Valacyclovir 1000 mg twice daily for 7–10 days. For recurrent genital herpes: Valacyclovir 500 mg twice daily for 3–5 days. For daily suppressive therapy: Valacyclovir 500 mg once daily reduces recurrences by 70–80%. 

Frequently Asked Questions

Can HIV be cured with antiretroviral therapy? 

Current ART does not cure HIV — it suppresses viral replication to undetectable levels, preventing immune damage and HIV transmission. With consistent adherence, people living with HIV on ART have a near-normal life expectancy. Missing doses allows viral rebound and resistance development. 

What does ‘undetectable equals untransmittable’ (U=U) mean? 

U=U is a clinically validated principle: people living with HIV on sustained ART who maintain an undetectable viral load (below 200 copies/mL) cannot sexually transmit HIV to partners. This is the foundation of treatment-as-prevention (TasP). 

What is TDF and how is it different from TAF? 

Both are tenofovir prodrugs — NRTIs used as the backbone of ART regimens. TAF (Tenofovir Alafenamide) delivers tenofovir more efficiently at a lower dose, resulting in significantly lower plasma tenofovir levels — better renal and bone safety vs TDF. TAF is preferred in patients with renal impairment or osteoporosis risk. 

How long does Valacyclovir suppress genital herpes? 

Valacyclovir 500 mg once daily as suppressive therapy reduces HSV recurrences by approximately 70–80% and reduces asymptomatic viral shedding (and therefore transmission risk) by over 50%. It can be taken indefinitely and is very well tolerated. 

Is there a risk of drug resistance with herpes antivirals? 

Resistance to Acyclovir and Valacyclovir is rare (less than 1%) in immunocompetent patients. It occurs more frequently in severely immunocompromised patients (advanced HIV, transplant recipients), where Foscarnet or Cidofovir may be required as alternatives. 

Do I need to tell partners if I take suppressive herpes therapy? 

Suppressive therapy significantly reduces but does not eliminate transmission risk. Disclosure to sexual partners remains important. Using condoms in addition to suppressive therapy provides the greatest reduction in transmission risk.